Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation

Yo Fujii1, Masayoshi Yada, Masaaki Nishiyama

  • 1Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582.

Cancer Science
|July 26, 2006
PubMed

Insights

Loss of Fbxw7, a key tumor suppressor, leads to the accumulation of cell-cycle promoters like cyclin E and c-Myc. This accumulation drives cancer cell proliferation and growth, highlighting Fbxw7

Area of Science:

  • * Molecular biology
  • * Cancer research
  • * Cell cycle regulation

Background:

  • * Fbxw7 (F-box and WD repeat domain-containing protein 7) is an SCF ubiquitin ligase component.
  • * Fbxw7 targets cell-cycle promoters and oncogenic proteins like cyclin E, c-Myc, and Aurora-A for degradation.
  • * Loss of Fbxw7 function is implicated in oncogenesis due to substrate accumulation.

Purpose of the Study:

  • * To investigate the relationship between Fbxw7 mutations and the accumulation of its substrates (cyclin E, c-Myc, Aurora-A) in cancer cells.
  • * To determine which accumulating substrate is most critical for cancer development in Fbxw7-mutant cells.
  • * To assess the impact of substrate accumulation on cancer cell proliferation and growth.

Main Methods:

  • * Analysis of cyclin E, c-Myc, and Aurora-A protein levels in seven cancer cell lines with wild-type or mutant Fbxw7.
  • * Forced expression of Fbxw7 in mutant cells to observe substrate level changes.
  • * RNA interference to decrease cyclin E, c-Myc, or Aurora-A expression in Fbxw7-mutant cells.
  • * Assessment of cell proliferation and anchorage-independent growth rates.

Main Results:

  • * Fbxw7-mutant cancer cells showed elevated levels of cyclin E, c-Myc, and Aurora-A, though the extent varied.
  • * Forced Fbxw7 expression reduced these substrate levels in mutant cells.
  • * Depletion of cyclin E, c-Myc, or Aurora-A significantly inhibited proliferation and anchorage-independent growth of Fbxw7-mutant cells.

Conclusions:

  • * Loss of Fbxw7 function leads to the accumulation of multiple growth-promoting substrates, including cyclin E, c-Myc, and Aurora-A.
  • * These accumulated substrates are essential for the proliferation and growth of Fbxw7-mutant cancer cells.
  • * Fbxw7's role in regulating multiple targets is crucial for suppressing cancer development.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...